Evidence map›Paper›PMID 35893810›Full record

ArticlePharmaceutics2022

Comparative Preclinical Study of Lidocaine and Mepivacaine in Resilient Hyaluronic Acid Fillers.

Romain Brusini, Julien Iehl, Elodie Clerc, Mélanie Gallet, François Bourdon, Jimmy Faivre

Abstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Rheology as a Tool to Investigate the Degradability of Hyaluronic Acid Dermal Fillers.Clinical, cosmetic and investigational dermatology · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Romain BrusiniResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.
Julien IehlResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.
Elodie ClercResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.
Mélanie GalletResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.
François BourdonResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.
Jimmy FaivreResearch and Development Department, Teoxane SA, Rue de Lyon 105, 1203 Geneva, Switzerland.ORCID 0000-0003-4695-1816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyaluronic acid-based filler injections are now well-established aesthetic procedures for the correction of skin tissue defects and volume loss. Filler injections are becoming increasingly popular, with a growing number of injections performed each year. Although classified as a minimally invasive procedure, the introduction of a needle or a canula may remain painful for the patient. A major improvement was achieved with the incorporation of local anesthetics into the formulation for pain relief.

methodsIn this study, two well-known anesthetics, lidocaine and mepivacaine, were systematically compared to assess their influence on filler mechanical and biological features. The impact of each anesthetic was monitored in terms of gel rheological properties, stability, durability, and degradation. The release profiles of each anesthetic were also recorded. Finally, the pharmacokinetics of each anesthetic in rats were assessed.

resultsFor all the rheological and biological experiments performed, lidocaine and mepivacaine influences were comparable. The addition of either anesthetic into a soft-tissue filler showed no significant modifications of the stability, durability, and degradability of the gel, with similar release profiles and pharmacokinetics at an equivalent concentration.

conclusionsSubstituting lidocaine with mepivacaine does not impact the properties of the gels, and thus both can be equally incorporated as anesthetics in soft-tissue fillers.

Indexed as

anestheticshyaluronic acidlidocainemepivacainepharmacokineticsreleasesoft-tissue fillers

Identifiers

PMID35893810
PMCPMC9329866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.